Cambrian is a distributed development company building therapeutics to lengthen health span.
Cambrian Biopharma has raised $123.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2026.
Cambrian Biopharma's investors include Alumni Ventures, Future Ventures, FJ Labs, Catalio Capital Management, Galaxy Digital.
Cambrian Biopharma is headquartered in New York, United States.
Cambrian is a distributed development company building therapeutics to lengthen health span.
Cambrian Biopharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cambrian Biopharma — Funding & Investors." VCBacked, July 15, 2026, https://www.vcbacked.co/company/cambrian-biopharma. Accessed August 14, 2026.
VCBacked. (2026). Cambrian Biopharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cambrian-biopharma
{{cite web |title=Cambrian Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/cambrian-biopharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated